repository
Pharmaceutical composition comprising indolizine derivative for activating stimulator of interferon gene dependent signaling
- Author(s)
- 민준식
- Alternative Author(s)
- Junsik Min
- Advisor
- 김은하
- Department
- 일반대학원 분자과학기술학과
- Publisher
- The Graduate School, Ajou University
- Publication Year
- 2021-02
- Language
- eng
- Alternative Abstract
- During the past few decades, cancer immunotherapy has emerged as a promising cancer treatment expected to overcome the limitations of conventional chemotherapy. Immune checkpoint inhibitors (ICIs) that block the interaction between receptors/ligands of major immune checkpoint molecules such as programmed cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) have attracted attention for their excellent and sustained clinical efficacy. However, there are limitations such as efficacy in the only subset of patients or carcinomas and resistance to treatment. In particular, cold tumors exhibiting a tumor microenvironment with immune-excluded or immune-desert phenotype have defects in the early stages of the immune cycle avoidance mechanism; hence, their responsiveness to ICIs is poor. Therefore, there is a need for innate immunity-inducing agents that increase the immune response by stimulating pattern recognition receptors such as stimulator of interferon genes (STING). The stimulator of interferon genes (STING) is an endoplasmic reticulum-localized adaptor that has been shown to be activated by natural cyclic dinucleotide (CDN) ligands, leading to STING dimerization, and downstream signaling to trigger innate immune gene transcription. Multiple reports demonstrated that activation of the STING protein by cyclic dinucleotide (CDN) trigger antitumor immunity. However, the inherent instability of CDN has limited current efforts. Herein, we developed a new synergy drug candidate for STING agonist, based on indolizine chemical core skeleton. The compound exhibited excellent efficacy for activating the STING signaling pathway without toxicity in combination with cGAMP, STING agonist. We envisioned the candidate could serve as a chemical tool to discover a new important regulator for the STING-mediated immunity.
- Fulltext
- Appears in Collections:
- Graduate School of Ajou University > Department of Molecular Science and Technology > 3. Theses(Master)
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
- STATISTICS
- Total Visit :4,070,155
- Total Download :1,967
- Today View :585
